Peer-reviewedCC BYFrontiers in cardiovascular medicine
Atrial fibroblast metabolic reprogramming in atrial fibrillation: a candidate mechanism within multicellular atrial cardiomyopathy
- 1Department of Cardiology, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University , , ,
Related
- Anthracycline Cardiotoxicity as Multicellular Network Failure: Cardiac Niche Reprogramming and Pathological Cell–Cell Communication
- Fibroblast Activation Protein Inhibitor Positron Emission Tomography Imaging in Atrial Fibrillation: Current Evidence and Future Perspectives
- Recurrence Rates and Outcomes After First Detected Atrial Fibrillation Episode in a Contemporary Hypertrophic Cardiomyopathy Center
- Life-long management of atrial fibrillation in a patient with hypertrophic obstructive cardiomyopathy following alcohol septal ablation: A10-year follow-up case report
- A TERRA-NONO axis drives fibroblast reprogramming in cancer
BibTeX
@article{jiang2026atrial,
title = {{Atrial fibroblast metabolic reprogramming in atrial fibrillation: a candidate mechanism within multicellular atrial cardiomyopathy}},
author = {Xiao-hai Jiang and Run-zhong Wang and Ya-wen Sheng and Ling Liu},
journal = {Frontiers in cardiovascular medicine},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13655352},
note = {CC BY},
}
RIS
TY - JOUR
TI - Atrial fibroblast metabolic reprogramming in atrial fibrillation: a candidate mechanism within multicellular atrial cardiomyopathy
AU - Xiao-hai Jiang
AU - Run-zhong Wang
AU - Ya-wen Sheng
AU - Ling Liu
PY - 2026
DA - 2026/10/16
JO - Frontiers in cardiovascular medicine
UR - https://europepmc.org/article/PMC/PMC13655352
SN - 2297-055X
ER -